[Common variable immunodeficiency (CVID) -- variable immunodeficiency syndrome].
Suter-Meyer
E
E
Medizinische Poliklinik, Universitätsspital Zürich.
Nigg
C
C
Naumann
U Kolyvanos
UK
Käser
L
L
Vetter
W
W
D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D017074:Common Variable Immunodeficiency / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D003937:Diagnosis, Differential; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007136:Immunoglobulins / Q000097:blood; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000627:therapeutic use; D008017:Life Expectancy; D008297:Male; D011247:Pregnancy; D011379:Prognosis; D013997:Time Factors; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous